(1 - 27 from 35
)
Google News: Patients, clinicians welcome Avastin for ovarian cancer
[Pharma Times] - Louise Bayne, chief executive of the charity Ovacome, said the drug's licensing "heralds a new era of hope for women diagnosed with ovarian cancer, who have previously been faced with a devastating diagnosis plus a lack of innovative treatments," while
Biggest ovarian cancer breakthrough in 15 years
www.mirror.co.uk
[Mirror.co.uk] - Louise Bayne, chief executive of the charity Ovacome, said: “We are delighted. This heralds a new era of hope for women with ovarian cancer who have previously been faced with a devastating diagnosis plus a lack of innovative treatments.
Debate on ovarian cancer: for a public awareness solution
www.thetimes.co.uk
14 Apr — Louise Bayne is CEO of Ovacome, the ovarian cancer support network. I have been involved with Ovacome for eight years. › article
Patient Seminar ESGO-ENGAGe
engage.esgo.org
Louise Bayne, CEO Ovacome, UK, speaking about their leading initiatives in Ovarian cancer. Doris Schmitt, PATH, Germany presenting the Patient-driven breast ... › events › previous › patient-se...
sorted by relevance / date